Literature DB >> 8597614

Occlusion of the superior mesenteric artery in a patient with polycythemia vera: resolution with percutaneous transluminal angioplasty.

X Bertrán1, J Muchart, R Planas, M I Real, J M Ribera, E Cabré, M Menacho, M A Gassull.   

Abstract

The case is reported of a 46-year-old male patient with polycythemia vera (PV) treated with phlebotomy who developed an occlusive thrombosis of the superior mesenteric artery 2 years after the diagnosis. He was successfully managed with percutaneous transluminal angioplasty. The patient did not develop any other thrombotic phenomena. To our knowledge, there are no previous reports on the use of percutaneous transluminal angioplasty in the management of arterial thrombotic complications in PV patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8597614     DOI: 10.1007/bf00641315

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  21 in total

1.  Complications and causes of death in polycythaemia vera.

Authors:  E CHIEVITZ; T THIEDE
Journal:  Acta Med Scand       Date:  1962-11

2.  Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.

Authors:  A P Tartaglia; J D Goldberg; P D Berk; L R Wasserman
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

3.  Compression of the celiac trunk and abdominal angina.

Authors:  J D Dunbar; W Molnar; F F Beman; S A Marable
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1965-11

4.  Intestinal angina: percutaneous transluminal angioplasty of the celiac and superior mesenteric arteries.

Authors:  A Odurny; K W Sniderman; R F Colapinto
Journal:  Radiology       Date:  1988-04       Impact factor: 11.105

5.  The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group.

Authors:  Y Najean; C Dresch; J D Rain
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

Review 6.  Budd-Chiari syndrome: etiology, diagnosis and management.

Authors:  M C Mitchell; J K Boitnott; S Kaufman; J L Cameron; W C Maddrey
Journal:  Medicine (Baltimore)       Date:  1982-07       Impact factor: 1.889

7.  Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications.

Authors:  A Weinfeld; B Swolin; J Westin
Journal:  Eur J Haematol       Date:  1994-03       Impact factor: 2.997

8.  Treatment of intestinal angina by percutaneous transluminal angioplasty of a superior mesenteric artery occlusion.

Authors:  N G Warnock; P A Gaines; J D Beard; D C Cumberland
Journal:  Clin Radiol       Date:  1992-01       Impact factor: 2.350

9.  Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.

Authors:  E Orlandi; G Castelli; E Brusamolino; A Canevari; E Morra; M Lazzarino; C Bernasconi
Journal:  Haematologica       Date:  1989 Jan-Feb       Impact factor: 9.941

10.  Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

Authors:  P D Berk; J D Goldberg; P B Donovan; S M Fruchtman; N I Berlin; L R Wasserman
Journal:  Semin Hematol       Date:  1986-04       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.